|
|
|
|
|
|
|
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura, Shun Kaneko, Masato Miyoshi, Fukiko Kawai-Kitahata, Sayuri Nitta, Jun Tsuchiya, Taro Shimizu, Keiya Watakabe, Tomohiro Mochida, Kento Inada, Yasuhiro Iizuka, Hideki Sakai, Yuki Sakurai, Ayako Sato, Seishin Azuma, Takahiro Kawamura, Chiaki Maeyashiki, Masayuki Kurosaki, Fumihiko Kusano, Hideki Watanabe, Hitoshi Kurata, Yuko Karakama, Takeo Fujiwara, Yuki Nagata, Toshihiro Tanaka, Sei Kakinuma, Ryuichi Okamoto, Yasuhiro Asahina: High serum gamma-glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma. Hepatol Res. 2024.12; 54 (12): 1128-1138. ( PubMed , DOI )
Yotaro Motomura, Kota Yoshifuji, Keisuke Tanaka, Chizuko Sakashita, Yoshihiro Umezawa, Toshikage Nagao, Sayuri Nitta, Yasuhiro Asahina, Takehiko Mori, Masahide Yamamoto: Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. J Clin Exp Hematop. 2024.11; Online ahead of print ( PubMed , DOI )
Yuki Tahata, Hayato Hikita, Satoshi Mochida, Nobuyuki Enomoto, Norifumi Kawada, Akio Ido, Daiki Miki, Masayuki Kurosaki, Hitoshi Yoshiji, Ryotaro Sakamori, Hidekatsu Kuroda, Hiroshi Yatsuhashi, Taro Yamashita, Yoichi Hiasa, Naoya Kato, Hisamitsu Miyaaki, Yoshiyuki Ueno, Yoshito Itoh, Kentaro Matsuura, Taro Takami, Yasuhiro Asahina, Goki Suda, Norio Akuta, Ryosuke Tateishi, Yasunari Nakamoto, Eiji Kakazu, Shuji Terai, Masahito Shimizu, Masanori Miyazaki, Yasutoshi Nozaki, Satoshi Sobue, Hiroki Yano, Tomokatsu Miyaki, Akihiro Moriuchi, Takeshi Hori, Kumiko Shirai, Kazuhiro Murai, Yoshinobu Saito, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara: Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy. Hepatol Res. 2024.10; Online ahead of print ( PubMed , DOI )
Jun Tsuchiya, Masato Miyoshi, Sei Kakinuma, Fukiko Kawai-Kitahata, Akihide Kamiya, Taro Shimizu, Ayako Sato, Keiya Watakabe, Tomohiro Mochida, Kento Inada, Rion Kamimae, Shun Kaneko, Miyako Murakawa, Sayuri Nitta, Mina Nakagawa, Mamoru Watanabe, Yasuhiro Asahina, Ryuichi Okamoto: Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model. Cell Mol Gastroenterol Hepatol. 2024.10; Online ahead of print 101422. ( PubMed , DOI )
Watakabe K, Miyoshi M, Kakinuma S, Sato A, Tsuchiya J, Shimizu T, Mochida T, Inada K, Kaneko S, Kawai-Kitahata F, Murakawa M, Nitta S, Nakagawa M, Oshima S, Watanabe M, Ma A, Asahina Y, Okamoto R: A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokines. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2024.07; 38 (13): e23757. ( PubMed , DOI )
Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, Shunsuke Ueyama, Chiaki Maeyashiki, Hideki Watanabe, Akiko Kusano-Kitazume, Ayako Sato, Kozue Uchidate, Takehito Asakawa, Sho Watanabe, Yasuhiro Iizuka, Isamu Shibata, Shinya Oooka, Yuko Karakama, Takashi Fujii, Taro Watabe, Keiichi Akahoshi, Minoru Tanabe, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Fukiko Kitahata-Kawai, Sayuri Nitta, Mina Nakagawa, Sei Kakinuma, Ryuichi Okamoto, : Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. Hepatol Res. 2024.06; 54 (6): 562-574. ( PubMed , DOI )
Haruki Uojima, Kazumi Yamasaki, Masaya Sugiyama, Masayoshi Kage, Norihiro Ishii, Ken Shirabe, Hisashi Hidaka, Chika Kusano, Miyako Murakawa, Yasuhiro Asahina, Takashi Nishimura, Hiroko Iijima, Kazumasa Sakamoto, Kiyoaki Ito, Keisuke Amano, Takumi Kawaguchi, Nobuharu Tamaki, Masayuki Kurosaki, Takanori Suzuki, Kentaro Matsuura, Akinobu Taketomi, Satoru Joshita, Takeji Umemura, Sohji Nishina, Keisuke Hino, Hidenori Toyoda, Hiroshi Yatsuhashi, Masashi Mizokami: Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation. J Gastroenterol. 2024.04; Online ahead of print ( PubMed , DOI )
Tatsuya Suzuki, Yuka Hayakawa, Shun Kaneko, Kento Takenaka, Keiya Watakabe, Yuko Kinowaki, Akira Takemoto, Kazuo Ohtsuka, Yasuhiro Asahina, Ryuichi Okamoto: Granulomatous hepatitis with Crohn's disease: a case report. Clin J Gastroenterol. 2024.03; Online ahead of print (3): 551-556. ( PubMed , DOI )
Keito Suzuki, Yutaka Yasui, Kaoru Tsuchiya, Hiroaki Matsumoto, Yudai Yamazaki, Naoki Uchihara, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada-Shimizu, Taisei Keitoku, Risa Okada, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Hiroyuki Nakanishi, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi: Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. J Gastroenterol Hepatol. 2024.03; Online ahead of print ( PubMed , DOI )
Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, Seishin Azuma, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Fukiko Kawai-Kitahata, Sayuri Nitta, Marie Takahashi, Tomoyuki Fujioka, Mitsuhiro Kishino, Tatsuhiko Anzai, Sei Kakinuma, Mina Nakagawa, Ryuichi Okamoto: Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades. PLoS One. 2024; 19 (3): e0297882. ( PubMed , DOI )
Nanako Hashido, Masanori Kobayashi, Ami Kawamoto, Suguru Mabuchi, Hiromune Katsuda, Kazuo Ohtsuka, Yasuhiro Asahina, Masayoshi Hashimoto, Ryuichi Okamoto: Sphincter of Oddi dysfunction that could not be diagnosed with Rome IV: a case report. Clin J Gastroenterol. 2023.12; 16 (6): 913-918. ( PubMed , DOI )
Haruki Uojima, Kadzuki Nakabayashi, Kazumi Yamasaki, Masaya Sugiyama, Norihiro Ishii, Ken Shirabe, Takuya Kyoutou, Koji Ueda, Yoichi Takahama, Nobuharu Tamaki, Masayuki Kurosaki, Hisashi Hidaka, Chika Kusano, Keisuke Amano, Takumi Kawaguchi, Akinobu Taketomi, Satoru Joshita, Takeji Umemura, Miyako Murakawa, Yasuhiro Asahina, Takanori Suzuki, Kentaro Matsuura, Takashi Nishimura, Hiroko Iijima, Kazumasa Sakamoto, Kiyoaki Ito, Sohji Nishina, Keisuke Hino, Hidenori Toyoda, Hiroshi Yatsuhashi, Masayoshi Kage, Masashi Mizokami: New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease. J Gastroenterol. 2023.12; 58 (12): 1252-1260. ( PubMed , DOI )
Yuki Tahata, Hayato Hikita, Satoshi Mochida, Nobuyuki Enomoto, Akio Ido, Hidekatsu Kuroda, Daiki Miki, Masayuki Kurosaki, Yoichi Hiasa, Ryotaro Sakamori, Norifumi Kawada, Taro Yamashita, Goki Suda, Hiroshi Yatsuhashi, Hitoshi Yoshiji, Naoya Kato, Taro Takami, Kazuhiko Nakao, Kentaro Matsuura, Yasuhiro Asahina, Yoshito Itoh, Ryosuke Tateishi, Yasunari Nakamoto, Eiji Kakazu, Shuji Terai, Masahito Shimizu, Yoshiyuki Ueno, Norio Akuta, Masanori Miyazaki, Yasutoshi Nozaki, Masayuki Kabayama, Satoshi Sobue, Akihiro Moriuchi, Tomokatsu Miyaki, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara: Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus. J Gastroenterol. 2023.12; 58 (12): 1211-1221. ( PubMed , DOI )
Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Tsubasa Nobusawa, Hiroaki Matsumoto, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi: Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy. J Viral Hepat. 2023.04; 30 (4): 297-302. ( PubMed , DOI )
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. J Gastroenterol. 2023.04; 58 (4): 299-310. ( PubMed , DOI )
Naoki Ikeda, Hiroaki Kubota, Risa Suzuki, Mitsuki Morita, Ayana Yoshimura, Yuya Osada, Keigo Kishida, Daiki Kitamura, Ayaka Iwata, Satoshi Yotsumoto, Daisuke Kurotaki, Koutarou Nishimura, Akira Nishiyama, Tomohiko Tamura, Takashi Kamatani, Tatsuhiko Tsunoda, Miyako Murakawa, Yasuhiro Asahina, Yoshihiro Hayashi, Hironori Harada, Yuka Harada, Asumi Yokota, Hideyo Hirai, Takao Seki, Makoto Kuwahara, Masakatsu Yamashita, Shigeyuki Shichino, Masato Tanaka, Kenichi Asano: The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis. Cell Rep. 2023.03; 42 (3): 112165. ( PubMed , DOI )
Shun Ishido, Kaoru Tsuchiya, Yoshihito Kano, Yutaka Yasui, Kenta Takaura, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Urara Sakurai, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi: Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2023.01; 15 (3): 719. ( PubMed , DOI )
Kaneko S, Asahina Y, Nakagawa M, Murakawa M, Miyazaki Y, Asakage T, Fukuda S, Namiki T, Kano Y, Nagata M, Tsuchiya J, Miyoshi M, Kitahata-Kawai F, Nitta S, Itsui Y, Kakinuma S, Okamoto R: Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Hepatology research : the official journal of the Japan Society of Hepatology. 2023.01; 53 (5): 450-459. ( PubMed , DOI )
Shokichi Takahama, Sachiyo Yoshio, Yuji Masuta, Hirotomo Murakami, Ryotaro Sakamori, Shun Kaneko, Takashi Honda, Miyako Murakawa, Masaya Sugiyama, Masayuki Kurosaki, Yasuhiro Asahina, Tetsuo Takehara, Victor Appay, Tatsuya Kanto, Takuya Yamamoto: T cell quality. Front Immunol. 2023; 14 1257113. ( PubMed , DOI )
Shuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi: Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy. Cancer Rep (Hoboken). 2022.11; 5 (11): e1613. ( PubMed , DOI )
Yuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Shun Kaneko, Yuki Tanaka, Shun Ishido, Kento Inada, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi , Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi: Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice Investigational New Drugs. 2021.10;
Yuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Shun Kaneko, Yuki Tanaka, Shun Ishido, Kento Inada, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi: Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice. Invest New Drugs. 2021.09; ( PubMed , DOI )
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LL, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Cammà C, Bruix J, Cabibbo G, Reig M: Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut. 2021.03; ( PubMed , DOI )
Yuki Tahata, Hayato Hikita, Satoshi Mochida, Norifumi Kawada, Nobuyuki Enomoto, Akio Ido, Hitoshi Yoshiji, Daiki Miki, Yoichi Hiasa, Yasuhiro Takikawa, Ryotaro Sakamori, Masayuki Kurosaki, Hiroshi Yatsuhashi, Ryosuke Tateishi, Yoshiyuki Ueno, Yoshito Itoh, Taro Yamashita, Tatsuya Kanto, Goki Suda, Yasunari Nakamoto, Naoya Kato, Yasuhiro Asahina, Kentaro Matsuura, Shuji Terai, Kazuhiko Nakao, Masahito Shimizu, Taro Takami, Norio Akuta, Ryoko Yamada, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara: Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study. J Gastroenterol. 2021.01; 56 (1): 67-77. ( PubMed , DOI )
Yasuhiro Asahina, Chun-Jen Liu, Edward Gane, Yoshito Itoh, Norifumi Kawada, Yoshiyuki Ueno, Jin Youn, Chen-Yu Wang, Joe Llewellyn, Takuma Matsuda, Anuj Gaggar, Hongmei Mo, Hadas Dvory-Sobol, Gerald Crans, Wan-Long Chuang, Pei-Jer Chen, Nobuyuki Enomoto: Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials. Hepatol Res. 2020.10; 50 (10): 1109-1117. ( PubMed , DOI )
Mina Nakagawa, Nobutoshi Nawa, Eiko Takeichi, Taro Shimizu, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Takeo Fujiwara, Mamoru Watanabe, Yujiro Tanaka, Yasuhiro Asahina: Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs. J Gastroenterol. 2020.08; 55 990-999. ( PubMed , DOI )
Yasuhiro Asahina, and Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology: JSH guidelines for the management of hepatitis C virus infection, 2019 update; protective effect of antiviral therapy against hepatocarcinogenesis. Hepatol Res. 2020.07; 50 (7): 775-790. ( PubMed , DOI )
Ryoichi Ando, Yasuhiro Asahina, Kazuaki Chayama, Naoki Hiramatsu, Toru Ikegami, Namiki Izumi, Kan Kikuchi, Kazuhiko Koike, Masayuki Kurosaki, Satoshi Mochida, Fumitaka Suzuki, Tetsuo Takehara, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hiroshi Yotsuyanagi; Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology: Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update. Hepatol Res. 2020.07; 50 (7): 791-816. ( PubMed , DOI )
Tetsuo Takehara, Kazuaki Chayama, Masayuki Kurosaki, Hiroshi Yatsuhashi, Yasuhito Tanaka, Naoki Hiramatsu, Naoya Sakamoto, Yasuhiro Asahina, Akito Nozaki, Toshikazu Nakano, Yosuke Hagiwara, Hiroko Shimizu, Hiroki Yoshida, Yuhan Huang, Michael Biermer, Leen Vijgen, Norio Hayashi: JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study. J Gastroenterol. 2020.06; 55 (6): 640-652. ( PubMed , DOI )
Sayuri Nitta, Kazuaki Takahashi, Fukiko Kawai-Kitahata, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe, Yasuhiro Asahina: Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient. Hepatol Res. 2020.04; 50 (4): 524-531. ( PubMed , DOI )
Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mao Okada, Wan Wang, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Namiki Izumi: Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma. PLoS One. 2020.04; 15 (4): e0231828. ( PubMed , DOI )
Ryoichi Ando, Yasuhiro Asahina, Kazuaki Chayama, Naoki Hiramatsu, Toru Ikegami, Namiki Izumi, Kan Kikuchi, Kazuhiko Koike, Masayuki Kurosaki, Satoshi Mochida, Fumitaka Suzuki, Tetsuo Takehara, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hiroshi Yotsuyanagi; Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology: JSH guidelines for the management of hepatitis B virus infection: 2019 Update. Hepatol Res. 2020.04;
Ayako Sato, Sei Kakinuma, Masato Miyoshi, Akihide Kamiya, Tomoyuki Tsunoda, Shun Kaneko, Jun Tsuchiya, Taro Shimizu, Eiko Takeichi, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe: Vasoactive intestinal peptide derived from liver mesenchymal cells mediates tight junction assembly in mouse intrahepatic bile ducts. Hepatol Commun. 2020.02; 4 (2): 235-254. ( PubMed , DOI )
Sayuri Nitta, Kazuaki Takahashi, Fukiko Kawai-Kitahata, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Miyako Murakawa, Yasuhiro Istui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe, Yasuhiro Asahina: Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient Hepatology Research. 2020; 50 (4): 524-531.
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Tomoyuki Tsunoda, Emi Inoue-Shinomiya, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Minoru Tanabe, Emiko Sugawara, Akira Takemoto, Hidenori Ojima, Michiie Sakamoto, Masaru Muraoka, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe: Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma. Hepatol Res. 2019.12; 49 (12): 1466-1474. ( PubMed , DOI )
Wan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mao Okada, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi: Sorafenib-Regorafenib sequential therapy in Japanese patients with unresectable hepatocellular carcinoma-relative dose intensity and post-regorafenib therapies in real world practice. Cancers (Basel). 2019.10; 11 (10): E1517. ( PubMed , DOI )
Tomoyuki Tsunoda, Sei Kakinuma, Masato Miyoshi, Akihide Kamiya, Shun Kaneko, Ayako Sato, Jun Tsuchiya, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Tsuyoshi Sogo, Haruki Komatsu, Ryutaro Mukouchi, Ayano Inui, Tomoo Fujisawa, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe: Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. J. Hepatol.. 2019.07; 71 (1): 143-152. ( PubMed , DOI )
Emi Inoue-Shinomiya, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Jun Tsuchiya, Ayako Sato, Tomoyuki Tsunoda, Masato Miyoshi, Sayuri Nitta, Fukiko Kawai-Kitahata, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Kazumoto Murata, Masashi Mizokami, Mamoru Watanabe: Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents. Hepatol. Res.. 2019.05; 49 (5): 500-511. ( PubMed , DOI )
Akira Doi, Hayato Hikita, Yugo Kai, Yuki Tahata, Yoshinobu Saito, Tasuku Nakabori, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Asako Murayama, Sayuri Nitta, Yasuhiro Asahina, Hiroshi Suemizu, Tomohide Tatsumi, Takanobu Kato, Tetsuo Takehara: Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice. J. Gastroenterol.. 2019.05; 54 (5): 449-458. ( PubMed , DOI )
Sayuri Nitta, Yasuhiro Asahina, Takanobu Kato, Jun Tsuchiya, Emi Inoue-Shinomiya, Ayako Sato, Tomoyuki Tsunoda, Masato Miyoshi, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Hayato Hikita, Tetsuo Takehara, Mamoru Watanabe: Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients. Sci Rep. 2019.04; 9 (1): 5722. ( PubMed , DOI )
Masato Miyoshi, Sei Kakinuma, Akihide Kamiya, Tomoyuki Tsunoda, Jun Tsuchiya, Ayako Sato, Shun Kaneko, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe: LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Sci Rep. 2019.02; 9 (1): 2072. ( PubMed , DOI )
Seishin Azuma, Yasuhiro Asahina, Sei Kakinuma, Keiko Azuma, Masato Miyoshi, Emi Inoue, Tomoyuki Tsunoda, Ayako Sato, Shun Kaneko, Hiroko Nagata, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Makoto Tomita, Mina Nakagawa, Mamoru Watanabe: Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. [Epub ahead of print] Dig Dis. 2019.01; 1-8. ( PubMed , DOI )
Yasuhiro Asahina, Yoshito Itoh, Yoshiyuki Ueno, Yasushi Matsuzaki, Yasuhiro Takikawa, Hiroshi Yatsuhashi, Takuya Genda, Fusao Ikeda, Takuma Matsuda, Hadas Dvory-Sobol, Deyuan Jiang, Benedetta Massetto, Anu O Osinusi, Diana M Brainard, John G McHutchison, Norifumi Kawada, Nobuyuki Enomoto: Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection. Liver Int. 2018.09; 38 (9): 1552-1561. ( PubMed , DOI )
Maekawa Shinya, Sato Mitsuaki, Kuratomi Natsuhiko, Inoue Taisuke, Suzuki Yuichiro, Tatsumi Akihisa, Miura Mika, Matsuda Shuya, Muraoka Masaru, Nakakuki Natsuko, Amemiya Fumitake, Takano Shinichi, Fukasawa Mitsuharu, Nakayama Yasuhiro, Yamaguchi Tatsuya, Sato Tadashi, Sakamoto Minoru, Murakawa Miyako, Nakagawa Mina, Asahina Yasuhiro, Enomoto Nobuyuki: Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C J. Gastroenterol. 2018.06; 53 (6): 780-786. ( 医中誌 )
Wai-Kay Seto, Yasuhiro Asahina, Todd T Brown, Cheng-Yuan Peng, Carol Stanciu, Dzhamal Abdurakhmanov, Fehmi Tabak, Tuan T Nguyen, Wan-Long Chuang, Tetsuro Inokuma, Fusao Ikeda, Teresa Antonia Santantonio, François Habersetzer, Alnoor Ramji, Audrey H Lau, Vithika Suri, John F Flaherty, Hongyuan Wang, Anuj Gaggar, G Mani Subramanian, Shrikant Mukewar, Maurizia R Brunetto, Scott Fung, Henry Lik-Yuen Chan: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.[Epub ahead of print] Clin. Gastroenterol. Hepatol. 2018.06; ( PubMed , DOI )
Yutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, Takaya Takeguchi, Yuko Takeguchi, Mao Okada, Wan Wang, Yohei Kubota, Tomoyuki Goto, Yasuyuki Komiyama, Mayu Higuchi, Kenta Takaura, Tsuguru Hayashi, Hitomi Takada, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Yoshiro Himeno, Namiki Izumi: Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization. Hepatol. Res. 2018.05; 48 (6): 442-450. ( PubMed , DOI )
Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina: Reply to: "Imaging Basis of AFP and WFA+M2BP as Indicators of the risk of HCC after SVR". J. Hepatol. 2018.03; 68 (3): 607-608. ( PubMed , DOI )
Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Ayako Sato, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Toshihiko Nouchi, Hideki Sakai, Makoto Tomita, Mamoru Watanabe: Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. J. Hepatol. 2017.11; 67 (5): 933-939. ( PubMed , DOI )
Kaneko Shun, Kakinuma Sei, Asahina Yasuhiro, Kamiya Akihide, Miyoshi Masato, Tsunoda Tomoyuki, Inoue-Shinomiya Emi, Nitta Sayuri, Sato Ayako, Asano Yu, Nagata Hiroko, Kawai-Kitahata Fukiko, Murakawa Miyako, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Watanabe Mamoru: A novel culture model for coinfection of hepatitis B and hepatitis C viruses using human induced pluripotent stem cell-derived hepatic cells for analyses of changes in host-innate immune responses HEPATOLOGY. 2017.10; 66 69A.
Nakagawa Mina, Asahina Yasuhiro, Nagata Hiroko, Kaneko Shun, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Azuma Seishin, Kakinuma Sei, Tanaka Yujiro, Watanabe Mamoru: Evaluation of an early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C patients treated with All-Oral DAAs - propensity score-matched analysis of a prospective database HEPATOLOGY. 2017.10; 66 38A-39A.
Nitta Sayuri, Murakawa Miyako, Kato Takanobu, Sato Ayako, Tsunoda Tomoyuki, Miyoshi Masato, Asano Yu, Kaneko Shun, Nagata Hiroko, Kawai-Kitahata Fukiko, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Asahina Yasuhiro: The analysis of NS5A Resistance-Associated Substitutions (RAS): In vitro study of NS5A recombinant hepatitis C in infectious cell culture system for various RAS detected after treatment failure in chronic hepatitis C patients HEPATOLOGY. 2017.10; 66 480A.
Murakawa Miyako, Asahina Yasuhiro, Nakagawa Mina, Nitta Sayuri, Kawai-Kitahata Fukiko, Nagata Hiroko, Kaneko Syun, Asano Yu, Miyoshi Masato, Tsunoda Tomoyuki, Inoue-Shinomiya Emi, Sato Ayako, Itsui Yasuhiro, Kakinuma Sei, Azuma Seishin, Watanabe Mamoru: On-treatment higher levels of alpha-fetoprotein and M2BPGi are associated with development of hepatocellular carcinoma during nucleos(t)ide analog therapy in patients with HBV chronic infection HEPATOLOGY. 2017.10; 66 507A.
Murakawa Miyako, Asahina Yasuhiro, Nagata Hiroko, Nakagawa Mina, Kakinuma Sei, Nitta Sayuri, Kawai-Kitahata Fukiko, Otani Satoshi, Kaneko Shun, Miyoshi Masato, Tsunoda Tomoyuki, Asano Yu, Sato Ayako, Itsui Yasuhiro, Azuma Seishin, Nouchi Toshihiko, Furumoto Yohei, Asano Tooru, Chuganji Yoshimichi, Tohda Shuji, Watanabe Mamoru: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin Hepatology Research. 2017.10; 47 (11): 1212-1218. ( 医中誌 )
Asahina Yasuhiro, Itoh Yoshito, Ueno Yoshiyuki, Matsuzaki Yasushi, Takikawa Yasuhiro, Yatsuhashi Hiroshi, Genda Takuya, Ikeda Fusao, Matsuda Takuma, Huang K. C., Massetto Benedetta, Osinusi Anu O., Brainard Diana M., McHutchison John G., Kawada Norifumi, Enomoto Nobuyuki: Ledipasvir/Sofosbuvir in the Treatment of Japanese Patients with Chronic HCV Genotype 2 Infection HEPATOLOGY. 2017.10; 66 638A.
Azuma Seishin, Asahina Yasuhiro, Kakinuma Sei, Azuma Keiko, Watanabe Mamoru: Diabetic retinopathy as a risk factor associated with development of hepatocellular carcinoma in non-alcoholic fatty liver disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2017.09; 32 158.
Tamaki N, Kurosaki M, Kusakabe A, Orito E, Joko K, Kojima Y, Kimura H, Uchida Y, Hasebe C, Asahina Y, Izumi N, Japanese Red Cross Hospital Liver Study Group.: Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon. Journal of viral hepatitis. 2017.08; 24 (8): 672-678. ( PubMed , DOI )
Goto Fumio, Kakinuma Sei, Miyoshi Masato, Tsunoda Tomoyuki, Kaneko Shun, Sato Ayako, Asano Yu, Otani Satoshi, Azuma Seishin, Nagata Hiroko, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Nakagawa Mina, Asahina Yasuhiro, Watanabe Mamoru: Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells Hepatology Research. 2017.08; 47 (9): 941-952. ( 医中誌 )
Kentaro Matsuura, Hiromi Sawai, Kazuho Ikeo, Shintaro Ogawa, Etsuko Iio, Masanori Isogawa, Noritomo Shimada, Atsumasa Komori, Hidenori Toyoda, Takashi Kumada, Tadashi Namisaki, Hitoshi Yoshiji, Naoya Sakamoto, Mina Nakagawa, Yasuhiro Asahina, Masayuki Kurosaki, Namiki Izumi, Nobuyuki Enomoto, Atsunori Kusakabe, Eiji Kajiwara, Yoshito Itoh, Tatsuya Ide, Akihiro Tamori, Misako Matsubara, Norifumi Kawada, Ken Shirabe, Eiichi Tomita, Masao Honda, Shuichi Kaneko, Sohji Nishina, Atsushi Suetsugu, Yoichi Hiasa, Hisayoshi Watanabe, Takuya Genda, Isao Sakaida, Shuhei Nishiguchi, Koichi Takaguchi, Eiji Tanaka, Junichi Sugihara, Mitsuo Shimada, Yasuteru Kondo, Yosuke Kawai, Kaname Kojima, Masao Nagasaki, Katsushi Tokunaga, Yasuhito Tanaka, : Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. Gastroenterology. 2017.05; 152 (6): 1383-1394. ( PubMed , DOI )
Miyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, Mina Nakagawa, Sei Kakinuma, Sayuri Nitta, Fukiko Kawai-Kitahata, Satoshi Otani, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Ayako Sato, Yasuhiro Itsui, Seishin Azuma, Toshihiko Nouchi, Yohei Furumoto, Tooru Asano, Yoshimichi Chuganji, Shuji Tohda, Mamoru Watanabe: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatol. Res.. 2017.01; ( PubMed , DOI )
Miyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, Mina Nakagawa, Sayuri Nitta, Satoshi Otani, Hiroko Nagata, Shun Kaneko, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Yasuhito Tanaka, Sayuki Iijima, Kaoru Tsuchiya, Namiki Izumi, Shuji Tohda, Mamoru Watanabe: Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. [Epub ahead of print] J. Med. Virol.. 2016.12; ( PubMed , DOI )
Hitomi Takada, Kaoru Tsuchiya, Yutaka Yasui, Natsuko Nakakuki, Nobuharu Tamaki, Shoko Suzuki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi: Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Cancer Med. 2016.11; 5 (11): 3111-3120. ( PubMed , DOI )
Sayuri Nitta, Yasuhiro Asahina, Mami Matsuda, Norie Yamada, Ryuichi Sugiyama, Takahiro Masaki, Ryosuke Suzuki, Nobuyuki Kato, Mamoru Watanabe, Takaji Wakita, Takanobu Kato: Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents. Sci Rep. 2016.10; 6 34652. ( PubMed , DOI )
Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, Yukio Osaki, Kouji Joko, Hitoshi Yagisawa, Shinya Sakita, Hiroaki Okushin, Takashi Satou, Hiroyuki Hisai, Takehiko Abe, Keiji Tsuji, Takashi Tamada, Haruhiko Kobashi, Akeri Mitsuda, Yasushi Ide, Chikara Ogawa, Syotaro Tsuruta, Kouichi Takaguchi, Miyako Murakawa, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi: Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure. PLoS ONE. 2016.10; 11 (10): e0165339. ( PubMed , DOI )
Masato Miyoshi, Sei Kakinuma, Yoko Tanabe, Koji Ishii, Tian-Cheng Li, Takaji Wakita, Yukio Tsuura, Hideki Watanabe, Yasuhiro Asahina, Mamoru Watanabe, Takaaki Ikeda: Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy. Intern. Med. 2016.10; 55 (19): 2811-2817. ( PubMed , DOI )
Fumio Goto, Sei Kakinuma, Masato Miyoshi, Tomoyuki Tsunoda, Shun Kaneko, Ayako Sato, Yu Asano, Satoshi Otani, Seishin Azuma, Hiroko Nagata, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Yasuhiro Asahina, Mamoru Watanabe: Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol. Res. 2016.09; 47 (9): 941-952. ( PubMed , DOI )
Hiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Fumio Goto, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Naoko Tojo, Shuji Tohda, Yasuhiro Asahina, Mamoru Watanabe, : Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.[Epub ahead of print] Hepatol Int. 2016.07; ( PubMed , DOI )
Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina, Akihide Kamiya, Masato Miyoshi, Tomoyuki Tsunoda, Sayuri Nitta, Yu Asano, Hiroko Nagata, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Hiromitsu Nakauchi, Hironori Nishitsuji, Saneyuki Ujino, Kunitada Shimotohno, Masashi Iwamoto, Koichi Watashi, Takaji Wakita, Mamoru Watanabe: Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep. 2016.07; 6 29358. ( PubMed , DOI )
Seishin Azuma, Yasuhiro Asahina, Yuki Nishimura-Sakurai, Sei Kakinuma, Shun Kaneko, Hiroko Nagata, Fumio Goto, Satoshi Ootani, Fukiko Kawai-Kitahata, Miki Taniguchi, Miyako Murakawa, Takako Watanabe, Megumi Tasaka-Fujita, Yasuhiro Itsui, Mina Nakagawa, Mamoru Watanabe: Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol. Res.. 2016.04; 46 (4): 312-319. ( PubMed , DOI )
Miki Taniguchi, Megumi Tasaka-Fujita, Mina Nakagawa, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Fumio Goto, Hiroko Nagata, Shun Kaneko, Sayuri Nitta, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Kenichi Mori, Shintaro Yagi, Sei Kakinuma, Yasuhiro Asahina, Mamoru Watanabe: Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System. J Clin Transl Hepatol. 2016.03; 4 (1): 5-11. ( PubMed , DOI )
Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu, Hiroshi Yotsuyanagi: JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2. Hepatol. Res. 2016.02; 46 (2): 129-165. ( PubMed , DOI )
Satoshi Otani, Sei Kakinuma, Akihide Kamiya, Fumio Goto, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Fukiko Kawai-Kitahata, Sayuri Nitta, Toru Nakata, Ryuichi Okamoto, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Yasuhiro Asahina, Tomoyuki Yamaguchi, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe: Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells. Biochem. Biophys. Res. Commun.. 2016.01; 469 (4): 1062-1068. ( PubMed , DOI )
Yasuhiro Asahina, Mamoru Watanabe: Need for appropriate programs for prevention of hepatitis B infection: Lessons from the latest nationwide survey in Japan. J. Gastroenterol. Hepatol. 2016.01; 31 (1): 12-13. ( PubMed , DOI )
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto, Hiroko Nagata, Shun Kaneko, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Mina Nakagawa, Minoru Tanabe, Shinichi Takano, Mitsuharu Fukasawa, Minoru Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe: Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. J. Gastroenterol. 2015.11; ( PubMed , DOI )
Megumi Tasaka-Fujita, Nao Sugiyama, Wonseok Kang, Takahiro Masaski, Asako Murayama, Norie Yamada, Ryuichi Sugiyama, Senko Tsukuda, Koichi Watashi, Yasuhiro Asahina, Naoya Sakamoto, Takaji Wakita, Eui-Cheol Shin, Takanobu Kato: Amino acid polymorphisms in hepatitis C virus core affect infectious virus production and major histocompatibility complex class I molecule expression. Sci Rep. 2015.09; 5 13994. ( PubMed , DOI )
Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, Hitomi Takada, Natsuko Nakakuki, Yutaka Yasui, Shoko Suzuki, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Shintaro Ogawa, Yasuhito Tanaka, Yasuhiro Asahina, Namiki Izumi: Genetic polymorphisms of IL28B and PNPLA3 are predictive for HCV related rapid fibrosis progression and identify patients who require urgent antiviral treatment with new regimens. PLoS ONE. 2015.09; 10 (9): e0137351. ( PubMed , DOI )
Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe: Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C. J. Gastroenterol. Hepatol. 2015.06; 30 (6): 1075-1084. ( PubMed , DOI )
Nobutoshi Komatsu, Utaroh Motosugi, Shinya Maekawa, Kuniaki Shindo, Minoru Sakamoto, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Mitsuharu Fukasawa, Tomoyoshi Uetake, Masahiko Ohtaka, Tadashi Sato, Yasuhiro Asahina, Masayuki Kurosaki, Namiki Izumi, Tomoaki Ichikawa, Tsutomu Araki, Nobuyuki Enomoto: Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging. Hepatol Res. 2014.12; 44 (13): 1339-1346. ( PubMed , DOI )
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, Masaru Muraoka, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Namiki Izumi: Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J. Gastroenterol. 2014.11; 49 (11): 1495-1503. ( PubMed , DOI )
Yoshihito Kano, Sei Kakinuma, Fumio Goto, Seishin Azuma, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Mina Nakagawa, Atsushi Kudo, Minoru Tanabe, Susumu Kirimura, Tomonori Amano, Takashi Ito, Takumi Akashi, Yasuhiro Asahina, Mamoru Watanabe: Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clin J Gastroenterol. 2014.10; 7 (5): 449-454. ( PubMed , DOI )
Yoshihito Kano, Sei Kakinuma, Fumio Goto, Seishin Azuma, Yuki Nishimura-Sakurai, Yasuhiro Itsui , Mina Nakagawa, Atsushi Kudo, Minoru Tanabe, Susumu Kirimura, Tomonori Amano, Takashi Ito , Takumi Akashi, Yasuhiro Asahina, Mamoru Watanabe: Primary Hepatic Neuroendocrine Carcinoma with a Cholangiocellular Carcinoma Component in One Nodule. Clinical Journal of Gastroenterology. 2014.10; 7 449-454.
Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, Ken Furuya, Mineo Kudo, Yoshimichi Chuganji, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terasita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kouji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Yasuyuki Fujita, Riichiro Abe, Miki Taniguchi, Mina Nakagawa, Yasuhiro Asahina, Naoya Sakamoto, : Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions. Hepatol Res.. 2014.09; ( PubMed , DOI )
Kaoru Tsuchiya, Yasuhiro Asahina, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi: Reply: To PMID 24734314. Liver Transpl. 2014.09; 20 (9): 1152. ( PubMed , DOI )
Yasuhiro Asahina, Kaoru Tsuchiya, Namiki Izumi: Reply: To PMID 23564522. Hepatology. 2014.08; 60 (2): 764. ( PubMed , DOI )
Yasuhiro Iizuka, Hideki Sakai, Konomi Kobayashi, Kazue Iizuka, Eri Ito, Nahoko Mochizuki, Yasuhiro Asahina, Mamoru Watanabe: A case of chronic hepatitis B managed with continued adefovir despite treatment-related Fanconi syndrome and osteomalacia. Nihon Shokakibyo Gakkai Zasshi. 2014.08; 111 (8): 1618-1623. ( PubMed )
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, Toru Nakata, Masaru Muraoka, Yuichiro Suzuki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Takashi Nishimura, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Kotaro Matsunaga, Kazuhiro Taki, Yasuhiro Asahina, Namiki Izumi: Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients. Hepatol Res. 2014.07; 44 (7): 720-727. ( PubMed , DOI )
Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi: Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C. J. Gastroenterol. 2014.07; 49 (7): 1152-1162. ( PubMed , DOI )
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, Kaoru Tsuchiya, Takamasa Noda, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Jun Itakura, Kimitaka Anami, Yasuhiro Asahina, Nobuyuki Enomoto, Teruhiko Higuchi, Namiki Izumi: Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res. 2014.03; 44 (3): 319-326. ( PubMed , DOI )
Kaoru Tsuchiya, Yasuhiro Asahina, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi: Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Liver Transpl. 2014.03; 20 (3): 291-297. ( PubMed )
Nao Nishida, Hiromi Sawai, Koichi Kashiwase, Mutsuhiko Minami, Masaya Sugiyama, Wai-Kay Seto, Man-Fung Yuen, Nawarat Posuwan, Yong Poovorawan, Sang Hoon Ahn, Kwang-Hyub Han, Kentaro Matsuura, Yasuhito Tanaka, Masayuki Kurosaki, Yasuhiro Asahina, Namiki Izumi, Jong-Hon Kang, Shuhei Hige, Tatsuya Ide, Kazuhide Yamamoto, Isao Sakaida, Yoshikazu Murawaki, Yoshito Itoh, Akihiro Tamori, Etsuro Orito, Yoichi Hiasa, Masao Honda, Shuichi Kaneko, Eiji Mita, Kazuyuki Suzuki, Keisuke Hino, Eiji Tanaka, Satoshi Mochida, Masaaki Watanabe, Yuichiro Eguchi, Naohiko Masaki, Kazumoto Murata, Masaaki Korenaga, Yoriko Mawatari, Jun Ohashi, Minae Kawashima, Katsushi Tokunaga, Masashi Mizokami: New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia. PLoS ONE. 2014.02; 9 (2): e86449. ( PubMed , DOI )
Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, Masaru Muraoka, Toru Nakata, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Takashi Nishimura, Ken Ueda, Teiji Kuzuya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi: Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma. Cancer. 2014.01; 120 (2): 229-237. ( PubMed , DOI )
Asahina Y, HayashinN, Hiramatsu N, Izumi N, Koike K, Kumada H, Kurosaki M,Oketani M, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H,Yotsuyanagi H: JSH Guidelines for the Management of Hepatitis B Virus Infection. Hepatol Res. 2014.01; 44 Suppl S1 1-58. ( PubMed , DOI )
Yasui Y, Kudo A, Kurosaki M, Matsuda S, Muraoka M, Tamaki N, Suzuki S, Hosokawa T, Ueda K, Matsunaga K, Nakanishi H, Tsuchiya K, Itakura J, Takahashi Y, Tanaka S, Asahina Y, Enomoto N, Arii S, Izumi N.: Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study. Oncology. 2014.01; 86 (1): 53-62. ( PubMed , DOI )
Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi: α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology. 2013.10; 58 (4): 1253-1262. ( PubMed , DOI )
Kei Kiyohashi, Sei Kakinuma, Akihide Kamiya, Naoya Sakamoto, Sayuri Nitta, Hideto Yamanaka, Kouhei Yoshino, Junko Fujiki, Miyako Murakawa, Akiko Kusano-Kitazume, Hiromichi Shimizu, Ryuichi Okamoto, Seishin Azuma, Mina Nakagawa, Yasuhiro Asahina, Naoki Tanimizu, Akira Kikuchi, Hiromitsu Nakauchi, Mamoru Watanabe: Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. Hepatology. 2013.06; 57 (6): 2502-2513. ( PubMed , DOI )
Kusano-Kitazume A, Sakamoto N, Okuno Y, Sekine-Osajima Y, Nakagawa M, Kakinuma S, Kiyohashi K, Nitta S, Murakawa M, Azuma S, Nishimura-Sakurai Y, Hagiwara M, Watanabe M: Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication. Antimicrob Agents Chemother. 2012.03; 56 (3): 1315-1323. ( PubMed , DOI )
Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Mishima K, Ueyama M, Onozuka I, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Watanabe M: Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J Virol. 2011.06; 85 (12): 5986-5994. ( PubMed , DOI )
Izumi Onozuka, Sei Kakinuma, Akihide Kamiya, Masato Miyoshi, Naoya Sakamoto, Kei Kiyohashi, Takako Watanabe, Yusuke Funaoka, Mayumi Ueyama, Mina Nakagawa, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe: Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Biochem. Biophys. Res. Commun.. 2011.03; 406 (1): 134-140. ( PubMed , DOI )
Yamamoto M, Sakamoto N, Nakamura T, Itsui Y, Nakagawa M, Nishimura-Sakurai Y, Kakinuma S, Azuma S, Tsuchiya K, Kato T, Wakita T, Watanabe M: Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture. Hepatol Res. 2011.03; 41 (3): 258-269. ( PubMed , DOI )
Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Nishimura-Sakurai Y, Itsui Y, Azuma S, Kakinuma S, Hige S, Ito Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M: Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b. J Med Virol. 2011.03; 83 871-878. ( PubMed , DOI )
Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, Naoya Sakamoto, Nobuyuki Enomoto, Masao Honda, Masaya Sugiyama, Kentaro Matsuura, Fuminaka Sugauchi, Yasuhiro Asahina, Mina Nakagawa, Mamoru Watanabe, Minoru Sakamoto, Shinya Maekawa, Akito Sakai, Shuichi Kaneko, Kiyoaki Ito, Naohiko Masaki, Katsushi Tokunaga, Namiki Izumi, Masashi Mizokami: Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. J. Hepatol.. 2011.03; 54 (3): 439-448. ( PubMed , DOI )
Ueyama M, Nakagawa M, Sakamoto N, Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M:: Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin. Antiviral Therapy. 2011; 16 1081-1091. ( PubMed , DOI )
Yasuhiro Itsui, Naoya Sakamoto, Sei Kakinuma, Mina Nakagawa, Yuko Sekine-Osajima, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Gouki Suda, Yuko Karakama, Kako Mishima, Machi Yamamoto, Takako Watanabe, Mayumi Ueyama, Yusuke Funaoka, Seishin Azuma, Mamoru Watanabe: Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology. 2009.12; 50 (6): 1727-1737. ( PubMed , DOI )
Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M: Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol. 2004.09; 78 (18): 9713-9720. ( PubMed , DOI )
三好 正人, 朝比奈 靖浩: 【今推しの肝胆膵研究手法と疾患モデル】新規モデルによる肝胆膵研究 iPS細胞を用いた肝疾患モデルの開発 肝胆膵. 2024.08; 89 (2): 215-221.
勝又 理沙, 金子 俊, 小林 正典, 中川 美奈, 勝田 景統, 加藤 祐己, 桐村 進, 大塚 和朗, 朝比奈 靖浩, 岡本 隆一: 経口胆道鏡にて診断しえた再発肝細胞癌の１例 日本消化器内視鏡学会雑誌. 2023.12; 65 (12): 2413-2420.
中川 美奈, 朝比奈 靖浩: 【ウイルス性肝炎学2023-最新の病態・診断・治療情報-】C型肝炎 ウイルス排除をめざした臨床研究 C型肝炎の治療と生命予後 日本臨床. 2023.07; 81 (増刊7): 122-128. ( 医中誌 )
金子 俊, 村川 美也子, 朝比奈 靖浩: 【ウイルス性肝炎学2023-最新の病態・診断・治療情報-】B型肝炎 治療 新規抗HBV薬剤の開発状況 日本臨床. 2023.07; 81 (増刊7): 417-424. ( 医中誌 )
中川 美奈, 村川 美也子, 金子 俊, 朝比奈 靖浩: 【肝疾患-診療のチェックポイント2023】(第I部)診断のチェックポイント(第7章) 慢性肝疾患における肝細胞癌診断のチェックポイント 臨床消化器内科. 2023.06; 38 (7): 853-859. ( DOI , 医中誌 )
中川美奈、朝比奈靖浩: 核酸アナログ投与下の合併症 消化器・肝臓内科. 2020.08; 8 (2): 171-177.
朝比奈靖浩: C型肝炎 病態と疫学動向 臨床とウイルス. 2020.07; 48 (2): 135-145.
朝比奈靖浩: B型慢性肝炎治療の肝発癌への影響 臨床消化器内科. 2020.02; 35 (2): 191-198.
朝比奈靖浩: iPS細胞を用いた研究の最前線 消化器・肝臓内科. 2019.09; 6 (3): 267-270.
朝比奈靖浩: 特集【B型肝炎治療におけるアンメットニーズ】4.B型肝炎治療の治療 2）将来の治療展望 Progress in Medicine. 2019.04; 39 (4): 31-35.
中川美奈、村川美也子、朝比奈靖浩: Post SVRにおけるM2BPGiの意義 肝胆膵. 2019.04; 78 (4): 604-614.
朝比奈靖浩: 臨床薬理学 慢性肝炎 別冊系統看護学講座. 2019; 137-145.
朝比奈靖浩: 診断と治療のABCウイルス性肝炎 (第2章)病理・病態生理 肝炎ウイルス関連肝がんのがんゲノム変異と発がん機構 最新医学 別冊ウイルス性肝炎. 2019; 142 57-66.
朝比奈靖浩: C型慢性肝炎 消化器疾患最新の治療2019-2020. 2019; 323-326.
朝比奈靖浩: 慢性肝炎・肝硬変 臨床検査のガイドライン. 2019; 337-345.
朝比奈靖浩: 【診断と治療のABC[142]ウイルス性肝炎】 (第2章)病理・病態生理 肝炎ウイルス関連肝がんのがんゲノム変異と発がん機構 最新医学(0370-8241)別冊ウイルス性肝炎. 2019; 57-66.
朝比奈靖浩: 【特集／B型肝炎の新たな展開 －進化を続ける基礎と臨床－】 肝発癌 基礎 HBV integration. 肝胆膵. 2019; 78 907-912.
朝比奈靖浩: 【肝線維化-診断を超えて】 肝線維化の非侵襲的評価法 バイオマーカーによる肝線維化診断 臨床消化器内科. 2018.11; 33 (13): 1613-1620. ( 医中誌 )
朝比奈靖浩: 【消化器治療薬の使い分け】抗ウイルス薬～B型肝炎～ レジデント. 2018.07; 11 (7): 62-70.
朝比奈靖浩: 肝がんスクリーニングにおけるAFPとPIVKA─IIとの同時測定の意義 Medical Practice. 2018.06; 35 (6): 977.
金子 俊, 朝比奈靖浩: 【肝疾患診療:残されたそして新たな課題】 C型非代償性肝硬変に対する抗HCV治療 肝臓クリニカルアップデート. 2018.05; 4 (1): 3-8. ( 医中誌 )
中川美奈、朝比奈靖浩: 【特集II/消化器疾患における性差医療を考える】肝炎ウイルスと性差 消化器・肝臓内科. 2018.05; 3 (5): 529-536.
新田沙由梨、加藤孝宣、朝比奈靖浩: 【特集Ⅱ：C型肝炎の最新治療とウイルス排除後の最適診療】治療不成功で生じる耐性変異－基礎的観点から－ 消化器・肝臓内科. 2018.04; ３ (４): 415-422.
朝比奈靖浩: 【B型肝炎診療の最前線】 新たな核酸アナログ・テノホビルアラフェナミドフマル酸塩(TAF)の有用性 日本医事新報. 2018.04; (4902): 37-43. ( 医中誌 )
中川美奈、永田紘子、朝比奈靖浩: 【特集： C型肝炎の新たな壁を越える次世代DAA治療】DAA治療による肝発癌・再発抑制効果-自験例から- 肝胆膵. 2018.02; 76 (2): 277-284.
朝比奈靖浩: C型肝炎治療の進歩と今後の課題 お茶の水医学雑誌. 2018.01; 66 (1): 55-65. ( 医中誌 )
朝比奈靖浩, 鈴木文孝, 田中靖人, 松本晶博, 四柳 宏: B型肝炎診療の最新知見と今後の展開 日本消化器病学会雑誌. 2018.01; 115 (1): 55-78. ( 医中誌 )
朝比奈靖浩: C型慢性肝炎、肝硬変：抗ウイルス療法 今日の治療指針. 2018; 527-531.
朝比奈靖浩: 【消化器治療薬の使い分け】 抗ウイルス薬 B型肝炎 月刊レジデント. 2018; 11 (7): 62-70.
朝比奈靖浩、北畑富貴子: 臨床家の立場から視た肝癌のゲノム解析と病態生理 肝癌の病態と関連する遺伝子変異 The Liver Cancer Journal. 2017.12; 9 (2): 110-115. ( 医中誌 )
朝比奈靖浩: 【医学と治療の最前線】ここまで進んだ肝癌の集学的治療 日本内科学会学会誌. 2017.10; 106 1481-1488.
朝比奈靖浩: 【特集：肝癌診療 A to Z】DAAs 治療後発癌 肝臓クリニカルアップデート. 2017.10; 3 (2): -.
朝比奈靖浩: 【消化器の臨床20年の歩み-消化器疾患治療はどう変わったか】 ウイルス性肝炎 特にB型・C型肝炎を中心に 消化器の臨床. 2017.10; 20 (5): 342-349. ( 医中誌 )
永田紘子、朝比奈靖浩: 【肝線維化診断の進歩】 M2BPGiの臨床的意義と実地での活用法 消化器・肝臓内科. 2017.10; 2 (4): 464-468. ( 医中誌 )
中川美奈、朝比奈靖浩: 【ここまで変わったC型肝炎の治療】 DAA治療のアウトカム 肝予備能、肝外臓器およびQOLへの影響 最新医学. 2017.09; 72 (9): 1291-1301. ( 医中誌 )
朝比奈 靖浩: 医学と医療の最前線 ここまで進んだ肝癌の集学的治療 日本内科学会雑誌. 2017.07; 106 (7): 1481-1488. ( 医中誌 )
北畑富貴子、朝比奈靖浩: 【内科医が知っておくべき肝癌治療最前線】 肝癌ゲノム解析の進歩 精密医療への展開を目指して 消化器・肝臓内科. 2017.07; 2 (1): 120-124. ( 医中誌 )
朝比奈靖浩: 【特集：ガイドラインには書いていない「肝炎・肝がん診療の最近の問題点」】C 型肝炎インターフェロン・フリー治療の残された課題 肝臓クリニカルアップデート. 2017.06; 3 (1): 35-39.
井津井康浩、朝比奈靖浩: 【肝臓を診る-肝臓病のキモ】肝疾患診療総論 採血データの読み方 データを深読みすると肝臓がまるみえに 内科. 2017.06; 119 (6): 1083-1088. ( 医中誌 )
朝比奈靖浩: 【ウイルス肝炎 実地診療に活用したいウイルス肝炎の最新情報】 セミナー 実地診療に活用したいウイルス肝炎の最新情報 C型肝炎ウイルス排除後の最適診療 Medical Practice. 2017.05; 34 (5): 781-786. ( 医中誌 )
永田紘子、朝比奈靖浩: 【激変する肝疾患診療の現状】 肝疾患の診断の進め方 臨牀と研究. 2017.05; 94 (5): 522-528. ( 医中誌 )
金子 俊、柿沼 晴、朝比奈靖浩: 【特集II：進化するB型肝炎治療】 ヒトiPS細胞由来肝細胞系譜細胞を用いたB型肝炎ウイルス感染培養系の構築 消化器・肝臓内科. 2017.04; 1 (4): 441-448.
朝比奈靖浩: 【ウイルス肝炎の院内感染防止のための個別予防策・治療 】ウイルス肝炎発症時のウイルス学的・疫学的調査 解説：透析医療における感染症ガイドライン. 2017.03; 131-137.
金子 俊、朝比奈靖浩: 【特集Ⅱ：C型肝炎治療の新時代】抗ウイルス療法後の発癌とその対策 消化器・肝臓内科. 2017.01; 1 (1): 95-101.
朝比奈靖浩: 【特集：臨床応用を見据えた肝線維化研究の新展開】海外における肝線維化治療薬の臨床開発状況 肝胆膵. 2017.01; 74 (1): 107-112.
朝比奈靖浩: 【こココが知りたい！治療の最前線】C型肝炎治療 調剤と情報. 2017.01; 23 (1): 37-43.
朝比奈 靖浩: 【臨床応用を見据えた肝線維化研究の新展開】 治療 海外における肝線維化治療薬の臨床開発状況 肝・胆・膵. 2017.01; 74 (1): 107-112. ( 医中誌 )
高田 ひとみ, 土谷 薫, 中岫 奈津子, 玉城 信治, 安井 豊, 鈴木 祥子, 中西 裕之, 板倉 潤, 高橋 有香, 黒崎 雅之, 朝比奈 靖浩, 伴 大輔, 工藤 篤, 田邊 稔, 田中 真二, 有井 滋樹, 榎本 信幸, 泉 並木: 集学的治療によりdown-stagingが得られ根治的肝切除が可能となり、長期生存を獲得し得た進行肝癌の4例 肝臓. 2016.12; 57 (12): 649-655. ( 医中誌 )
朝比奈靖浩: 【特集：インターフェロン・フリーC型肝炎治療】遺伝子型1型のC型肝炎の抗ウイルス治療（4）DAA併用ペグインターフェロン・リバビリン併用療法の適応と意義 臨床消化器内科. 2016.10; 31 (11): 1469-1474.
朝比奈靖浩: 【C型肝炎SVR後の肝発癌】 発癌リスクを考慮したC型肝炎の治療戦略 医学のあゆみ. 2016.10; 259 (4): 281-286. ( 医中誌 )
朝比奈靖浩: 【特集：肝癌治療を極める】◎若手に役立つ議論・オピニオンリーダーからのメッセージ：SVR 後の発癌リスク予測 M2BPGi の新たな発癌予測マーカーとしての有用性 肝臓クリニカルアップデート . 2016.10; 2 (2): 189-192.
金子 俊、柿沼 晴、朝比奈靖浩: iPS細胞由来肝細胞系譜細胞を用いたB型肝炎ウイルス感染培養系の構築 肝細胞研究会. 2016.09; 研究交流
武市瑛子、柿沼 晴、大谷賢志、小橋健一郎、東 正新、北畑富貴子、村川美也子、櫻井 幸、新田沙由梨、井津井康浩、中川美奈、朝比奈靖浩、渡辺 守: Direct-acting antiviralsによる抗ウイルス療法が著効し、C型肝炎ウイルス関連クリオグロブリン腎症が改善した一例 肝臓. 2016.08; 57 (8): 405-411. ( 医中誌 )
中川美奈、朝比奈靖浩、村川美也子、永田紘子、金子 俊、大谷賢志、北畑富貴子、新田沙由梨、櫻井 幸、井津井康浩、東 正新、柿沼 晴、今田安津子、伊藤 崇、谷合麻紀子、橋本悦子、田中雄二郎、渡辺 守: 5年にわたる経時的な経過観察の中で急激なエコー上変化をきたした原発性硬化性胆管炎の1例 肝臓. 2016.08; 57 (8): 382-390. ( 医中誌 )
朝比奈靖浩: トピックス：肝疾患診療の進歩 (2) C型肝炎 臨床病理. 2016.07; 64 (7): 780-786.
朝比奈靖浩: 第Ⅵ部 C型肝炎の経過・予後 ガイドライン準拠：C型肝炎治療Q&A. 2016.06; 138-144.
北畑富貴子、 朝比奈靖浩: 【目指せ!C型肝炎ウイルスの克服-肝がん制圧に向けての更なる挑戦-】 ここまで分かった!肝がんゲノムとは? 肝臓クリニカルアップデート. 2016.05; 2 (1): 39-43. ( 医中誌 )
朝比奈靖浩: 【特集：目指せ!C型肝炎ウイルスの克服-肝がん制圧に向けての更なる挑戦-】 序文 C 型肝疾患の完全克服を目指して 肝臓クリニカルアップデート. 2016.05; 2 (1): １.
井津井康浩、朝比奈靖浩: 【免疫不全患者における感染症の現状と展望】 肝硬変患者に合併する細菌感染症 最新医学. 2016.04; 71 (4): 781-784. ( 医中誌 )
朝比奈 靖浩: 【性感染症のすべて-病原体、診断、治療、予防】 ウイルス感染症 ウイルス肝炎 臨床と微生物. 2016.03; 43 (2): 151-156. ( 医中誌 )
朝比奈靖浩: 【ウイルス肝炎の院内感染防止のための個別予防策・治療】肝炎ウイルス感染者の治療. B型肝炎／C型肝炎／肝癌合併例 解説：透析医療における感染症ガイドライン. 2016.03; 138-144.
朝比奈靖浩: 【特集：C型肝炎治療の新たな展開―インターフェロン・フリー時代の幕開け】C型肝硬変に対する抗ウイルス療法 月間薬事. 2016.02; 58 (3): 81-85.
朝比奈靖浩: 【特集：C型肝炎ー薬物治療の最前線と求められる多角的視点ー】C型肝炎治療の変遷と最新の薬物治療戦略 ゲノタイプ2型C型肝炎 薬局. 2015.12; 66 (13): 3117-3122.
朝比奈靖浩: 【特集：C型肝炎ー最新のウイルス療法と今後の課題ー】C型肝炎からの発芽とその抑制を目指した治療の実際 消化器の臨床. 2015.12; 18 (6): 619-624.
中川美奈、朝比奈靖浩: 【新ウイルス性肝炎学 －最新の基礎・臨床研究情報－】特論２：C型肝炎IFN治療後の線維化マーカーと発癌リスク 日本臨床. 2015.12; (1090): 668-673.
新田沙由梨、坂本直哉、朝比奈靖浩: 【各論：1 C型肝炎（３）臨床をめざした基礎研究】HCV-NS4BのIFN-λ抑制作用 日本臨床【新ウイルス性肝炎学 ─最新の基礎・臨床研究情報─】. 2015.12; 73 (増刊号): 124-127.
朝比奈靖浩: 【C型肝炎】治療法の進歩で「治せる」ようになった 治療が大きく変わった! C型肝炎・B型肝炎・脂肪肝・肝硬変・肝がん (別冊NHKきょうの健康). 2015.12; 16-35.
朝比奈靖浩: 【C型慢性肝炎治療のパラダイムシフト-治療から治癒へ-】 治療困難な患者に対するC型肝炎治療 高齢者に対する抗ウイルス療法は? 肝・胆・膵. 2015.10; 71 (4): 715-719. ( 医中誌 )
朝比奈靖浩: 【知らないでは済まされない!感染症診療の最前線 一類感染症 C型肝炎 多剤耐性菌 どうなる感染症の医療現場】 C型肝炎治療の最前線! 肝がんの制圧に向けた新たな戦い アニムス. 2015.10; 20 (4): 9-16,26. ( 医中誌 )
朝比奈靖浩: 新しい診断・薬の情報 C型肝炎に対する新薬の核酸型ポリメラーゼ阻害薬(ソホスブビル)はどんな薬か? 肝臓クリニカルアップデート. 2015.10; 1 (2): 233-237. ( 医中誌 )
朝比奈靖浩: C型肝炎薬物治療の変遷 日本病院薬剤師会雑誌. 2015.09; 51 (9): 1081-1086. ( 医中誌 )
朝比奈靖浩: 【特集：変貌するウイルス肝炎治療：最新知見とさらなる課題】B型肝炎の最新知見ーHBs抗原量と抗ウイルス効果、肝発がんー 最新医学. 2015.09; 70 (9): 1770-1776.
朝比奈靖浩: 【肝炎治療の今後の展望ーウイルス肝炎は克服されるかー】日本肝臓学会 B型肝炎治療ガイドライン 臨床現場で役立つ最新の治療 Current Therapy. 2015.09; 33 (9): 53-58.
朝比奈靖浩: 【ウイルス肝炎の最新治療】Ｃ型肝炎の最新治療と今後の展望 東京都医師会雑誌. 2015.08; 68 (7): 44-48.
泉 並木、狩野吉康、朝比奈靖浩、今村道雄: C型肝炎に対する治療の進歩 肝臓クリニカルアップデート. 2015.05; 1 (1): 59-66. ( 医中誌 )
井津井康浩、朝比奈靖浩: 【最新のウイルス肝炎の実地日常診療 経口抗ウイルス薬をどう使っていくか】 より有効でより安全な経口抗ウイルス薬の使いかたと治療成績 HBV Peg-IFNの位置づけは? Medical Practice. 2015.03; 32 (3): 481-485. ( 医中誌 )
朝比奈靖浩: 【ウイルス肝炎の薬物治療 変わりゆく治療戦略】 ここまで変わったウイルス肝炎の治療 C型慢性肝炎 今後使用可能になるであろう新規抗ウイルス薬と薬剤耐性問題 Medicina. 2015.02; 52 (2): 314-318. ( 医中誌 )
中川美奈、朝比奈靖浩: 【いまB型・C型肝炎をどう治療するか】 【C型肝炎】プロテアーゼ阻害剤3剤併用療法の効果と注意点 消化器の臨床. 2015.02; 18 (1): 66-73. ( 医中誌 )
朝比奈靖浩: 【C型肝炎治療update】 治療 特殊な病態におけるC型肝炎治療 高齢者 日本臨床. 2015.02; 73 (2): 292-298. ( 医中誌 )
櫻井 幸、朝比奈靖浩: 【疾患と検査値の推移 急性肝炎】B型急性肝炎の現状とウイルスマーカーの推移 検査と技術. 2015.02; 43 (2): 135-139. ( 医中誌 )
泉 並木、朝比奈靖浩: 【肝炎】 最新の話題 アニムス. 2015.01; 20 (1): 3-8. ( 医中誌 )
朝比奈靖浩: 【大きく変わるC型肝炎治療】-インターフェロンフリーの時代は来るか： インターフェロンフリー療法の現状-効果と問題点 日本医事新報. 2014.11; (4723): 27-32. ( 医中誌 )
朝比奈靖浩: 【肝疾患の基礎と臨床】 最新のC型肝炎治療 Medical Science Digest. 2014.11; 40 (13): 631-634. ( 医中誌 )
朝比奈靖浩: 【特集：ダクラタスビル・アスナプレビル併用療法】 Ⅰ.総論- C型肝炎患者で進む高齢化：HCCリスクと治療の緊急性 肝胆膵. 2014.10; 69 (増刊): 603-608.
朝比奈靖浩, 泉 並木, 熊田博光, 黒崎雅之, 小池和彦, 鈴木文孝, 滝川 一, 田中 篤, 田中榮司, 田中 靖人, 坪内 博仁, 林 紀夫, 平松 直樹, 四柳 宏, 日本肝臓学会肝炎診療ガイドライン作成委員会: C型肝炎治療ガイドライン(第3版;抜粋) 肝臓. 2014.10; 55 (10): 634-644. ( 医中誌 )
朝比奈靖浩: 【C型肝炎治療-次世代DAAでHCV全員排除の時代へ-】 高齢者C型肝炎における抗ウイルス治療の考え方 Mebio. 2014.10; 31 (10): 49-55. ( 医中誌 )
井津井康浩, 朝比奈靖浩, 渡辺 守: 【シグナル伝達を理解するために必要な知識-第43回-】肝細胞癌のシグナル伝達と治療標的 分子消化器病. 2014.09; 11 (3): 277-282. ( 医中誌 )
飯塚 泰弘, 酒井 英樹, 小林 小の実, 飯塚 和絵, 伊東 英里, 望月 奈穂子, 朝比奈 靖浩, 渡辺 守: Fanconi症候群・骨軟化症のためAdefovirを中止し、軽快後に少量投与を再開しHBV-DNAをコントロール中のB型慢性肝炎の1例 日本消化器病学会雑誌. 2014.08; 111 (8): 1618-1623. ( 医中誌 )
朝比奈靖浩、新田沙由梨、渡辺 守: ［増刊号：C型肝炎のすべて】第III章 変貌したC型慢性肝炎の経過 6. C型慢性肝炎の抗ウイルス治療 (4) 自然免疫系と抗ウイルス治療効果 臨床消化器内科. 2014.06; 29 (7): 149-154.
朝比奈靖浩, 新田沙由梨, 渡辺 守: 【C型肝炎のすべて】 第III章 変貌したC型慢性肝炎の経過6. C型慢性肝炎の抗ウイルス治療 (4)自然免疫系と抗ウイルス治療効果 臨床消化器内科. 2014.05; 29 (7): 921-926. ( 医中誌 )
朝比奈靖浩: 【みえてきたC型肝炎征圧】 難治例の治療戦略 IL28B minor例に対する3剤併用療法-IL28B SNPが与える治療効果への影響 医学のあゆみ. 2014.04; 249 (3): 233-236. ( 医中誌 )
朝比奈靖浩: 【ここまで来た ウイルス肝炎治療】C型肝炎の発がん抑止 ASAHI medical. 2014.04; 43 (4): 21-23.
朝比奈靖浩, 四柳 宏, 平松直樹, 瀬崎ひとみ: 【ウイルス肝炎診療の最前線と今後の展開-日常臨床のポイントと知っておきたい最新情報-】肝炎診療の新展開と日常診療のコツ-実地医家と専門医の連携,未治療者の拾い上げを目指して 内科. 2014.04; 113 (4): 717-725. ( 医中誌 )
中川美奈, 朝比奈靖浩: 【ウイルス肝炎診療の最前線と今後の展開 日常臨床のポイントと知っておきたい最新情報】 C型肝炎治療の最前線 telaprevir 3剤併用療法-市販後の成績 内科. 2014.04; 113 (4): 663-667. ( 医中誌 )
櫻井 幸, 朝比奈 靖浩, 宍戸 華子, 井津井 康浩, 中川 美奈, 柿沼 晴, 東 正新, 東條 尚子, 渡辺 守: 多彩な超音波画像の変化を呈した原発性硬化性胆管炎の一例 超音波医学. 2014.04; 41 (Suppl.): S543. ( 医中誌 )
朝比奈靖浩: 【臨床検体から導き出す消化器病研究】 肝生検検体から導き出す宿主自然免疫と抗ウイルス効果の関連 分子消化器病. 2014.03; 11 (1): 36-41. ( 医中誌 )
朝比奈靖浩, 中川美奈, 渡辺 守: 【消化器薬-新時代の治療指針】 肝胆膵疾患 C型肝炎 Medicina. 2014.01; 51 (1): 70-74. ( 医中誌 )